CIK 0001808805 · Non-accelerated filer<br>Smaller reporting company
Nautilus Biotechnology, Inc.
Sign in to watch- Ticker
- NAUT
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981541723
- Phone
- 206-333-2001
- Business address
- 2701 EASTLAKE AVE EAST, SEATTLE, WA, 98102
- Former names
- ARYA Sciences Acquisition Corp III
- SC 13D/A Stake Beneficial Ownership Report
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- SC 13G Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K/A Event Executive or director change
- 8-K Event Results of operations · Bylaws or fiscal year change
- 4 Open-market buy Senior VP, Product Development bought 15,000 shares at an average $2.03 ($30,399)
- 4 Open-market buy Chief People Officer bought 30,000 shares at $2.03 ($60,765)
- 4 Open-market buy Senior VP, Product Development bought 75,000 shares at an average $2.18 ($163,198)
- 4 Open-market buy CFO and Treasurer bought 17,500 shares at $2.30 ($40,219)
- 4 Open-market buy General Counsel bought 10,000 shares at an average $2.84 ($28,433)
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- 4 Open-market buy CEO, President, and Secretary bought 50,000 shares at an average $2.92 ($146,090)
- 4 Derivatives Options or other derivatives
- POS AM Other Post-effective Amendment for Registration Statement
- 424B3 Offering Prospectus
- 10-Q Report Quarterly Report
Page 9 of 17 · 328 filings